Short-term fasting induces intra-hepatic lipid accumulation and decreases intestinal mass without reduced brush-border enzyme activity in mink (Mustela vison) small intestine

2004 ◽  
Vol 174 (8) ◽  
pp. 625-632 ◽  
Author(s):  
C. R. Bjornvad ◽  
J. Elnif ◽  
P. T. Sangild
2018 ◽  
Vol 26 (4) ◽  
pp. 1103-1115 ◽  
Author(s):  
Alexandre Abilio de Souza Teixeira ◽  
Camila O. Souza ◽  
Luana A. Biondo ◽  
Loreana Sanches Silveira ◽  
Edson A. Lima ◽  
...  

1980 ◽  
Vol 239 (5) ◽  
pp. G358-G362
Author(s):  
D. L. Kaminski ◽  
E. J. Mueller ◽  
M. Jellinek

Bypass of large segments of the small intestine to produce weight loss in morbidly obese human subjects has been associated with increased lipid accumulation in the liver. Congenital and nutritional obese rat models were employed to evaluate hepatic lipid accumulation following bypass of 90% of the small intestine. When small intestinal bypass was performed on nutritionally obese rats ingesting a high-fat diet (17%) supplemented with choline dihydrogen citrate (3,4 g/kg diet), a 59% loss of weight at 1 mo was unassociated with increased hepatic lipid accumulation when compared to sham-operated controls. When small intestinal bypass was performed on a nutritionally obese rat fed a relative choline-methionine-deficient diet following intestinal bypass, marked increases in total hepatic lipid and hepatic triglyceride content were evident when compared to the lipid content in sham-operated controls ingesting a similar choline-deficient diet. Hepatic steatosis following small intestinal bypass could be produced in a rat model only by a deficiency in a required substrate for triglyceride conversion to phospholipid and suggests that similar deficiencies may contribute to the increased hepatic lipid accumulation occurring in human subjects following intestinal bypass.


2021 ◽  
Author(s):  
Yilin Liu ◽  
Chunyan Xie ◽  
Zhenya Zhai ◽  
Ze-yuan Deng ◽  
Hugo R. De Jonge ◽  
...  

This study aimed to investigate the effect of uridine on obesity, fat accumulation in liver, and gut microbiota composition in high-fat diet-fed mice.


2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Paulus G. M. Jochems ◽  
Willem R. Keusters ◽  
Antoine H. P. America ◽  
Pascale C. S. Rietveld ◽  
Shanna Bastiaan-Net ◽  
...  

AbstractFood security is under increased pressure due to the ever-growing world population. To tackle this, alternative protein sources need to be evaluated for nutritional value, which requires information on digesta peptide composition in comparison to established protein sources and coupling to biological parameters. Here, a combined experimental and computational approach is presented, which compared seventeen protein sources with cow’s whey protein concentrate (WPC) as the benchmark. In vitro digestion of proteins was followed by proteomics analysis and statistical model-based clustering. Information on digesta peptide composition resulted in 3 cluster groups, primarily driven by the peptide overlap with the benchmark protein WPC. Functional protein data was then incorporated in the computational model after evaluating the effects of eighteen protein digests on intestinal barrier integrity, viability, brush border enzyme activity, and immune parameters using a bioengineered intestine as microphysiological gut system. This resulted in 6 cluster groups. Biological clustering was driven by viability, brush border enzyme activity, and significant differences in immune parameters. Finally, a combination of proteomic and biological efficacy data resulted in 5 clusters groups, driven by a combination of digesta peptide composition and biological effects. The key finding of our holistic approach is that protein source (animal, plant or alternative derived) is not a driving force behind the delivery of bioactive peptides and their biological efficacy.


2021 ◽  
pp. 1-26
Author(s):  
Kenta Maegawa ◽  
Haruka Koyama ◽  
Satoru Fukiya ◽  
Atsushi Yokota ◽  
Koichiro Ueda ◽  
...  

Abstract Enterohepatic circulation of 12α-hydroxylated (12αOH) bile acid (BA) is enhanced depending on the energy intake in high-fat diet-fed rats. Such BA metabolism can be reproduced using a diet supplemented with cholic acid (CA), which also induces simple steatosis, without inflammation and fibrosis, accompanied by some other symptoms that are frequently observed in the condition of non-alcoholic fatty liver in rats. We investigated whether supplementation of the diet with raffinose (Raf) improves hepatic lipid accumulation induced by the CA-fed condition in rats. After acclimation to the AIN-93-based control diet, male Wistar rats were fed diets supplemented with a combination of Raf (30 g/kg diet) and/or CA (0.5 g/kg diet) for 4 weeks. Dietary Raf normalised hepatic triglyceride levels (two-way ANOVA P<0.001 for CA, P=0.02 for Raf, and P=0.004 for interaction) in the CA-supplemented diet-fed rats. Dietary Raf supplementation reduced hepatic 12αOH BA concentration (two-way ANOVA P<0.001 for CA, P=0.003 for Raf, and P=0.03 for interaction). The concentration of 12αOH BA was reduced in the aortic and portal plasma. Raf supplementation increased acetic acid concentration in the caecal contents (two-way ANOVA P=0.001 as a main effect). Multiple regression analysis revealed that concentrations of aortic 12αOH BA and caecal acetic acid could serve as predictors of hepatic triglyceride concentration (R2=0.55, P<0.001). However, Raf did not decrease the secondary 12αOH BA concentration in the caecal contents as well as the transaminase activity in the CA diet-fed rats. These results imply that dietary Raf normalises hepatic lipid accumulation via suppression of enterohepatic 12αOH BA circulation.


Sign in / Sign up

Export Citation Format

Share Document